AFP and cancer: The effectiveness of sorafenib in reducing cancer cells replication was defined by the model parameter εr = 1/[1 + ψ1 × F(t)del], the value of ψ1 = 10 was obtained by AFP fitting and yielded a 13.5% decline once reached the steady state of drug activity.